
Medpace Holdings MEDP
$ 609.81
-3.66%
Medpace Holdings Total Shareholders Equity | MEDP
Annual Total Shareholders Equity Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 459 M | 826 M | 559 M | 386 M | 953 M | 806 M | 726 M | 599 M | 504 M | 611 M | 413 M | 402 M | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 953 M | 386 M | 604 M |
Quarterly Total Shareholders Equity Medpace Holdings
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 826 M | 434 M | 598 M | 459 M | 294 M | 172 M | 594 M | 826 M | 881 M | 764 M | 672 M | 559 M | 471 M | 391 M | 347 M | 386 M | 350 M | 283 M | 605 M | 953 M | 898 M | 852 M | 859 M | 806 M | 806 M | 806 M | 806 M | 726 M | 726 M | 726 M | 726 M | 599 M | 590 M | 590 M | 590 M | 509 M | 504 M | 504 M | 504 M | 611 M | 611 M | 611 M | 611 M | 413 M | 413 M | - | - | 402 M | - | - | 414 M | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 953 M | 172 M | 597 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | ||
|
Renalytix AI plc
RNLX
|
-7.85 M | - | 5.66 % | $ 22.7 M | ||
|
Meridian Bioscience
VIVO
|
368 M | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
-28 M | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
3.5 B | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
-144 M | - | -11.32 % | $ 1.1 M | ||
|
Brainsway Ltd.
BWAY
|
62.3 M | $ 8.53 | -2.29 % | $ 290 M | ||
|
Burning Rock Biotech Limited
BNR
|
535 M | $ 13.46 | 1.05 % | $ 142 M | ||
|
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
119 M | - | - | $ 608 M | ||
|
RadNet
RDNT
|
1.09 B | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
5.13 M | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
1.61 B | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-2.46 M | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
6.74 B | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
3.16 B | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
52.5 B | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
2.75 B | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
15.2 M | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
101 M | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
-99.3 M | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
44.4 M | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
184 M | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
6.5 B | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
471 M | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
2.72 B | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
1.71 B | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
11 B | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
1.11 B | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
303 M | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Biomerica
BMRA
|
2.63 M | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
22.4 M | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
1.09 B | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
61 M | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
606 M | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
ICON Public Limited Company
ICLR
|
9.19 B | $ 186.79 | -1.88 % | $ 14.6 B |